Aclarion, Inc. (NASDAQ:ACON – Get Free Report) was the recipient of a large decrease in short interest in March. As of March 15th, there was short interest totalling 122,800 shares, a decrease of 73.9% from the February 28th total of 471,200 shares. Based on an average daily trading volume, of 4,910,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 24.3% of the shares of the company are sold short.
Aclarion Trading Down 14.0 %
Shares of Aclarion stock opened at $12.12 on Friday. Aclarion has a twelve month low of $11.36 and a twelve month high of $6,241.05. The company has a 50-day simple moving average of $3.15 and a two-hundred day simple moving average of $35.61.
Analyst Upgrades and Downgrades
Separately, Maxim Group reissued a “hold” rating on shares of Aclarion in a report on Friday, December 13th.
About Aclarion
Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.
Featured Stories
- Five stocks we like better than Aclarion
- What Are Growth Stocks and Investing in Them
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- How to start investing in penny stocks
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.
